Related Experiment Video
Updated: Aug 16, 2026
Generation of Subcutaneous and Intrahepatic Human Hepatocellular Carcinoma Xenografts in Immunodeficient Mice
Published on: September 25, 2013
Transplantation for hepatocellular carcinoma
1Guy's, King's and St Thomas' School of Medicine, London, UK.
Insights
Liver transplantation offers a viable treatment for hepatocellular carcinoma (HCC) when surgical resection isn't possible. This approach expands treatment options for HCC patients, especially those with limited hepatic reserve.
Area of Science:
- Hepatology
- Surgical Oncology
- Transplant Surgery
Background:
- Surgical resection for hepatocellular carcinoma (HCC) has strict eligibility criteria, including no metastatic or bilobar disease and adequate hepatic reserve.
- These criteria exclude over 70% of HCC patients from surgical resection due to associated severe liver disease.
Purpose of the Study:
- To discuss the role and indications of liver transplantation as a definitive therapy for hepatocellular carcinoma (HCC).
Main Methods:
- Review of existing literature on liver transplantation outcomes for HCC.
- Analysis of survival rates based on tumor size and number post-transplantation.
Main Results:
- Liver transplantation bypasses the strict criteria required for surgical resection, offering an alternative for more HCC patients.
- While large tumors (>5 cm) or multiple tumors (>4) are associated with lower survival rates, smaller tumors show significantly improved outcomes.
- Survival rates for select HCC patients undergoing transplantation may approach those seen in transplantation for nonmalignant liver conditions.
Conclusions:
- Liver transplantation is a crucial therapeutic option for eligible hepatocellular carcinoma patients who are not candidates for surgical resection.
- Careful patient selection and consideration of tumor burden are essential for optimizing outcomes in HCC transplantation.
- Further research into the long-term efficacy of transplantation for HCC is warranted.
Abstract:
Three criteria should be met for patients with hepatocellular carcinoma (HCC) to be eligible for surgical resection: there should be no metastatic disease, there should be no bilobar disease, and the patient should be left with adequate hepatic reserve after surgery. Given the association of severe liver disease with HCC, these criteria are met by less than 30% of patients. In contrast, transplantation does not require that the second and third criteria be met in patients who are otherwise candidates for this procedure. Most reports have demonstrated that patients with tumors greater than 5 cm in size or patients with more than four tumors have low 5-year survival rates after transplantation, but the survival rates with smaller tumors are much better and it has even been suggested that survival may approach that of transplantation for nonmalignant conditions. This presentation will discuss the role and indications for transplantation as definitive therapy for HCC.
